Lipella Pharmaceuticals LIPO
LIPO
$0.00 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Lipella Pharmaceuticals Inc. (LIPO) Income towards Parent Company (2022 - 2025)

Updated

Lipella Pharmaceuticals (LIPO) posted Income towards Parent Company of -$1.25 million for Q3 2025, compared with -$1.44 million a year earlier.

Analysis

Lipella Pharmaceuticals Inc. (LIPO) Income towards Parent Company (2022 - 2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2025, Income towards Parent Company at Lipella Pharmaceuticals was $4.7 million; for FY2024, it was $5.02 million.

  • In prior years, Lipella Pharmaceuticals' Income towards Parent Company was -$4.62 million in FY2023, -$2.6 million in FY2022 and -$1.87 million in FY2021.
  • Quarterly Income towards Parent Company has run from a low of -$1.54 million in Q2 2023 to a high of $8.59 million in Q4 2024 over five years.
  • According to Business Quant data, Income towards Parent Company for the three prior quarters was -$1.33 million (Q2 2025), -$1.31 million (Q1 2025) and $8.59 million (Q4 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -1.25 Mn
Jun 30, 2025 -1.33 Mn
Mar 31, 2025 -1.31 Mn
Dec 31, 2024 8.59 Mn
Sep 30, 2024 -1.44 Mn
Jun 30, 2024 -938,146.00
Mar 31, 2024 -1.19 Mn
Dec 31, 2023 -688,884.00
Sep 30, 2023 -1.32 Mn
Jun 30, 2023 -1.54 Mn
Mar 31, 2023 -1.07 Mn
Dec 31, 2022 -363,925.00
Sep 30, 2022 -713,794.00
Jun 30, 2022 -782,024.00
Mar 31, 2022 -737,950.00
API Access

Lipella Pharmaceuticals Inc. Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=LIPO&period=max&api_key=YOUR_API_KEY